Unity Biotechnology, Inc. Total Liabilities and Equity
Unity Biotechnology, Inc. had Total Liabilities and Equity of $30.35 million as of 2025-03-31, per its 10-Q filed 2025-04-22.
Financial Statements › Balance Sheet
us-gaap:LiabilitiesAndStockholdersEquity · last filed 2025-04-22
- 2025-03-31: Liabilities and Equity $30.35M.
- 2024-12-31: Liabilities and Equity $37.66M.
- 2024-09-30: Liabilities and Equity $47.13M.
- 2024-06-30: Liabilities and Equity $53.52M.
| Period end | Liabilities and Equity | Liabilities and Equity as first filed |
|---|---|---|
| 2025-03-31 | $30.35M 10-Q · filed 2025-04-22 | |
| 2024-12-31 | $37.66M 10-Q · filed 2025-04-22 | |
| 2024-09-30 | $47.13M 10-Q · filed 2024-11-04 | |
| 2024-06-30 | $53.52M 10-Q · filed 2024-08-06 | |
| 2024-03-31 | $58.86M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $65.69M 10-K · filed 2025-03-07 | |
| 2023-09-30 | $69.27M 10-K · filed 2024-04-15 | |
| 2023-06-30 | $101.01M 10-K · filed 2024-04-15 | |
| 2023-03-31 | $114.25M 10-K · filed 2024-04-15 | |
| 2022-12-31 | $124.35M 10-K · filed 2024-04-15 | |
| 2022-09-30 | $136.24M 10-K · filed 2024-04-15 | $136.39M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $97.59M 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $112.47M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $124.71M 10-K · filed 2023-03-15 | |
| 2021-09-30 | $125.69M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $136.26M 10-Q · filed 2021-08-10 | |
| 2021-03-31 | $148.19M 10-Q · filed 2021-05-11 | |
| 2020-12-31 | $156.32M 10-K · filed 2022-03-15 | |
| 2020-09-30 | $174.97M 10-Q · filed 2020-11-04 | |
| 2020-06-30 | $164.70M 10-Q · filed 2020-07-31 | |
| 2020-03-31 | $157.79M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $151.22M 10-K · filed 2021-03-23 | |
| 2019-09-30 | $141.68M 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $154.21M 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $160.80M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $181.38M 10-K · filed 2020-03-11 | |
| 2018-09-30 | $194.72M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $208.46M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $144.10M 10-Q · filed 2018-06-07 | |
| 2017-12-31 | $102.02M 10-K · filed 2019-03-06 |